Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Impact of plasma pTau181 levels on clinician diagnostic confidence and management in memory and cognition clinics: A multi‐site before‐and‐after study
Saved in:
| Published in: | Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Impact of plasma pTau181 levels on clinician diagnostic confidence and management in memory and cognition clinics: A multi‐site before‐and‐after study
- Cerebrovascular reactivity and plasma p‐tau181 in Alzheimer's disease: Insights into APOE‐related vascular phenotypes
- Associations of plasma p‐Tau217 with cognitive domain performance in clinically unimpaired participants: Evidence from HABS‐HD
- Transient plasma p‐tau217 elevations after electroconvulsive therapy: A two‐case report
- Blood DNA methylation signature of cognitive reserve moderates the association between CSF tau pathology and memory in prodromal Alzheimer's disease
- Cerebrospinal fluid NPTX2/p‐tau ratio as a biomarker for cognitive decline in neurodegenerative diseases
- Enlarged perivascular spaces in subcortical white matter are linked to amyloid–tau depositions and cognitive decline: Data from a memory clinic in Thailand